June 25, 2010
Mumbai
CRISIL revises rating outlook on MEGHMANI ORGANICS to ‘Positive’
Rs.300 Million Cash Credit A/Positive (Reaffirmed; Outlook Revised
from ‘Stable’)
Rs.345 Million Standby Fund-Based Limits A/Positive (Reaffirmed; Outlook Revised
from ‘Stable’)
Rs.1700 Million Bill Discounting P1 (Reaffirmed)
Rs.900 Million Letter of Credit/Bank Guarantee* P1 (Reaffirmed)
Rs.185.8 Million Standby Non-Fund-Based Limits P1 (Reaffirmed)
Rs.120 Million Term Loan A/Stable (Withdrawn)
Rs.500 Million Short-Term Debt Programme P1 (Withdrawn)
*Letter of credit/bank guarantee are interchangeable.

CRISIL has revised its rating outlook on the long-term bank facilities of Meghmani Organics Ltd (Meghmani) to ‘Positive’ from ‘Stable’, and has reaffirmed the rating at ‘A’. The rating on the company’s outstanding short-term bank facilities has also been reaffirmed at ‘P1’. CRISIL has withdrawn its ‘P1’ rating on Meghmani’s short-term debt programme at the company’s request; there is no outstanding under this programme. The ‘A/Stable’ on the company’s term loan facility has also been withdrawn as the company has fully repaid this loan.

The outlook revision has been mainly driven by expectations of improvement in offtake across Meghmani’s business divisions, especially the pigments and caustic soda divisions. Also, the company’s debt-funded capital expenditure (capex) in 2009-10 (refers to financial year, April 1 to March 31) was less than expected, which resulted in lower debt levels and moderately improved gearing and debt protection metrics. The outlook revision also reflects CRISIL’s belief that, with continued healthy demand prospects and prudent capex, Meghmani will sustain the improvement in its financial risk profile over the medium term.

The ratings continue to be supported by Meghmani’s established market position in the pigments and agrochemicals segments, diversified customer base, and the significant cost advantage the company derives from its backward integration of operations into the manufacture of copper phthalocyanine blue (the key raw material for pigments), and cypermethric acid chloride, metaphenoxy benzaldehyde, and metaphenoxy benzyl alcohol (key intermediates in crop protection production). These rating strengths are partially offset by Meghmani’s large working capital requirements arising out of seasonality in its business.

For arriving at its ratings, CRISIL has combined the business and financial risk profiles of Meghmani and its subsidiaries, because all these entities are under a common management and have close operational and financial linkages.

Outlook: Positive
CRISIL believes that Meghmani’s credit risk profile will improve gradually over the medium term, supported by steady accruals and a progressive reduction in debt levels. The rating may be upgraded if Meghmani is able to maintain healthy utilisation levels at its caustic soda division, or the company improves its gearing and debt protection levels, supported by higher-than-expected profitability. Conversely, the outlook may be revised to ‘Stable’ if Meghmani undertakes a larger-than-expected debt-funded capex programme, or its profitability declines, because of lower realisations from its key products.

About the Company
Meghmani was established in 1986 by Mr. Jayanti Patel, Mr. Ashish Soparkar, Mr. Natwarlal Patel, Mr. Ramesh Patel, and Mr. Anand Patel. The company specialises in the manufacture of green and blue pigment products. These products are used in the manufacture of printing ink, plastics, paints, textiles, leather, and rubber. Meghmani also produces a wide variety of commonly used pesticides for crop and non-crop applications; the latter include public health, and insect control in wood preservation and food grain storage. In July 2009, the company commissioned its caustic soda plant, with an installed capacity of 113,000 tonnes per annum and powered by a 40-megawatt captive thermal power generation unit. The company is listed on the Singapore Stock Exchange, National Stock Exchange, and Bombay Stock Exchange.

For 2009-10, Meghmani (consolidated) reported a net profit of Rs.396 million on net sales of Rs.8.18 billion, against a net profit of Rs.372 million on net sales of Rs.7.91 billion for the preceding year.

Media Contacts Analytical Contact CRISIL Rating Desk
Mitu Samar
Head, Market Development & Communications
CRISIL Limited
Tel: +91-22- 3342 1838
Email: msamar@crisil.com

Tanuja Abhinandan
Market Development & Communications
CRISIL Limited
Tel: +91-22-3342 1818
Email: tabhinandan@crisil.com
Pawan Agrawal
Director - CRISIL Ratings
Tel: +91-22-3342 3301
Email: pagrawal@crisil.com

Anuj Sethi
Head - CRISIL Ratings
Tel: +91-44-6656 3108
Email: ansethi@crisil.com

Tel: +91-22-3342 3047 / 3342 3064
Email: CRISILratingdesk@crisil.com

Note:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution of its rationales for consideration or otherwise through any media including websites, portals etc.

CRISIL Complexity Levels are assigned to various types of financial instruments. The CRISIL Complexity Levels are available on www.crisil.com/complexity-levels. Investors are advised to refer to the CRISIL Complexity Levels for instruments that they propose to invest in. Investors can also call the CRISIL Helpline at +91 22 3342 3047 / + 91 22 3342 3064 with queries on specific instruments.


CRISIL is India's leading Ratings, Research, Risk and Policy Advisory company. CRISIL leverages its core strengths of credibility and analytical rigour to deliver opinions and solutions, that help clients mitigate and manage their business and financial risks, make markets function better, and help shape public policy. For more information, visit www.crisil.com.

Disclaimer: A CRISIL rating reflects CRISIL's current opinion on the likelihood of timely payment of the obligations under the rated instrument and does not constitute an audit of the rated entity by CRISIL. CRISIL ratings are based on information provided by the issuer or obtained by CRISIL from sources it considers reliable. CRISIL does not guarantee the completeness or accuracy of the information on which the rating is based. A CRISIL rating is not a recommendation to buy, sell, or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. All CRISIL ratings are under surveillance. Ratings are revised as and when circumstances so warrant. CRISIL is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of this product. CRISIL Ratings’ rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For the latest rating information on any instrument of any company rated by CRISIL, please contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (+91 22) 3342 3000.

June 25, 2010

http://www.crisil.com